SANA
SANA
NASDAQ · Biotechnology

Sana Biotechnology Inc

$3.15
+0.11 (+3.62%)
As of Jun 21, 10:11 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +1,172.4% upside
Low Target $23.55
Average Target $40.08
High Target $57.48
Current Price $3.15
Current
$3.15
Target
$40.08
$23.55 $40.08 avg $57.48
Scenario Analysis
Bear Case
$23.55
647.6%
Low target
Base Case
$40.08
+1,172.4%
Avg target
Bull Case
$57.48
+1,724.8%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$6.55
-51.9% from high
52-Week Low
$2.58
+22.1% from low
Target vs 52W High
$40.08
+511.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%